Apatite content of collagen materials dose-dependently increases pre-osteoblastic cell deposition of a cement line-like matrix

Bone. 2010 Jul;47(1):23-33. doi: 10.1016/j.bone.2010.03.010. Epub 2010 Mar 18.

Abstract

Bone matrix, mainly composed of type I collagen and apatite, is constantly modified during the bone remodeling process, which exposes bone cells to various proportions of mineralized collagen within bone structural units. Collagen-mineralized substrates have been shown to increase osteoblast activities. We hypothesized that such effects may be explained by a rapid secretion of specific growth factors and/or deposition of specific matrix proteins. Using MC3T3-E1 seeded for 32h on collagen substrates complexed with various apatite contents, we found that pre-osteoblasts in contact with mineralized collagen gave rise to a dose-dependent deposit of Vascular Endothelial Growth Factor-A (VEGF-A) and RGD-containing proteins such as osteopontin (OPN) and fibronectin (FN). This RGD-matrix deposition reinforced the cell adhesion to collagen-mineralized substrates. It was also observed that, on these substrates, this matrix was elaborated concomitantly to an increased cell migration, allowing a homogeneous coverage of the sample. This particular surface activation was probably done firstly to reinforce cell survival (VEGF-A) and adhesion (OPN, FN) and secondly to recruit and prepare surfaces for subsequent bone cell activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3 Cells
  • Animals
  • Apatites / pharmacology*
  • Biocompatible Materials / pharmacology*
  • Biomechanical Phenomena / drug effects
  • Bone Cements / pharmacology*
  • Bone Matrix / drug effects
  • Bone Matrix / metabolism*
  • Calcification, Physiologic / drug effects
  • Cell Adhesion / drug effects
  • Cell Movement / drug effects
  • Collagen / pharmacology*
  • Fibronectins / metabolism
  • Mice
  • Oligopeptides / pharmacology
  • Osteoblasts / cytology*
  • Osteoblasts / drug effects
  • Osteoblasts / metabolism*
  • Phenotype
  • Solubility / drug effects
  • Substrate Specificity / drug effects

Substances

  • Apatites
  • Biocompatible Materials
  • Bone Cements
  • Fibronectins
  • Oligopeptides
  • arginyl-glycyl-aspartic acid
  • Collagen